[目前较低风险骨髓质疏松性瘤的治疗选择]
1Department of Hematology, Kitasato University School of Medicine.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|November 6, 2024
概括
本综述讨论了较低风险的骨髓分裂性瘤 (LR-MDS) 的治疗策略,重点关注管理细胞衰竭和改善日本可用的治疗方法的血液形成.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 较低风险的骨髓分裂性瘤 (LR-MDS) 与细胞衰竭和血细胞功能障碍存在挑战.
- 目前的疗法旨在改善血液形成,但在有效性和适用性方面存在局限性.
研究的目的:
- 审查和讨论LR-MDS患者的治疗策略.
- 为指导LR-MDS治疗的临床决策.
主要方法:
- 审查目前在日本可用的治疗选择.
- 讨论LR-MDS治疗的指示和疗效.
主要成果:
- 有一系列的治疗方法,包括lenalidomide,ESAs,luspatercept和其他.
- 治疗选择通常具有有限的疗效和明确的适应症,使治疗决策复杂化.
结论:
- 对LR-MDS的有效治疗策略需要仔细考虑可用的选择及其局限性.
- 可能需要进一步的研究来优化LR-MDS管理.
相关概念视频
Bone Marrow Sampling and Transplants
292
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
292
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


